Lilly Now in Phase 3 Clinical Trial for Covid-19 Drug Baricitinib World Business June 15, 2020 New York-listed Eli Lilly and Company announced today that the first patient has been enrolled in a Phase 3 randomized,…
Lilly Starts World’s First Study of Potential Covid-19 Antibody Treatment in Humans Top Stories June 1, 2020 Healthcare firm Eli Lilly and Company announced that it has began the world’s first study of potential Covid-19 antibody treatment’s…
